A team has designed a new drug against malaria and identified its mechanism of action. In 2022, nearly 619,000 global deaths due to malaria were caused by Plasmodium falciparum, the most virulent ...
Novartis and the non-profit Medicines for Malaria Venture (MMV) have advanced a novel drug combination for malaria into a phase 3 programme, raising hopes of a regimen that could be used to treat ...
Final results from a landmark study looking at the use of GSK's Mosquirix malaria vaccine alongside antimalarial drugs and other measures have shown a 90%-plus reduction in cases. The study in ...
Researchers led by teams at the University of California, Riverside (UCR), the University of California, Irvine, and the Yale School of Medicine have developed a compound that they found to be ...
and deadly human malaria parasite. For decades, the parasite’s resistance to all antimalarial drugs has posed a big challenge for researchers working to stop the spread of the disease. A team led by ...
Citation: Synthetic compound shows promise against drug-sensitive, drug-resistant strains of human malaria parasites (2024, September 26) retrieved 20 October 2024 from https://medicalxpress.com ...